Chinese biopharmaceutical firm Kanova has secured RMB115 million (US$16.55 million) series A round of financing from Chinese venture capital firm Northern Light Venture Capital (NLVC), according to a statement released today by NLVC. Other investors including Tsinghua University’s investment vehicle Lotus Lake Ventures, Chinese private equity fund manager Suzhou Kington Capital, and Kanova’s backer in […]

Northern Light Leads $16M Series A Round In China’s Biopharma Firm Kanova appeared first on China Money Network.